| 17-May-13 01:04PM | ZALICUS INC. Financials EDGAR Online Financials |
| 10-May-13 01:04PM | ZALICUS INC. Financials EDGAR Online Financials |
| 08:49AM | InPlay: Zalicus presents data on novel, Oral, N- and T-type calcium channel blockers for the treatment of pain; says 'data demonstrate the significant progress' Briefing.com |
| 08:45AM | Zalicus Presents Data on Novel, Oral, N- and T-Type Calcium Channel Blockers for the Treatment of Pain Business Wire |
| 01:50AM | ZALICUS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 08-May-13 08:31AM | InPlay: Zalicus secures new $25 mln funding commitment from Lincoln Park Capital Briefing.com |
| 08:30AM | Zalicus Secures New $25 Million Funding Commitment from Lincoln Park Capital Business Wire |
| 01:35AM | ZALICUS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online |
| 03-May-13 09:08AM | ZALICUS INC. Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 02-May-13 01:39PM | Watching Zalicus Like A Hawk at Seeking Alpha |
| 12:09PM | 2 Biotechs Primed For Prosperity In 2013 at Seeking Alpha |
| 07:30AM | Zalicus Reports Financial Results for the First Quarter 2013 Business Wire |
| 12:37AM | ZALICUS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 01-May-13 01:00AM | ZALICUS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online |
| 19-Apr-13 01:31AM | ZALICUS INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran EDGAR Online -5.45% |
| 11-Apr-13 01:30AM | ZALICUS INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online -6.06% |
| 03-Apr-13 07:25AM | For Zalicus The Renewal Of Its Partnership With Novartis Will Be Vital For FY '13 Revenues at Seeking Alpha |
| 02-Apr-13 02:18PM | 4 Healthcare Stock Stories for Tuesday Investment Wellness at Wall St. Cheat Sheet |
| 08:02AM | Zalicus grantes patent covering formulations of Z160 theflyonthewall.com |
| 08:00AM | Zalicus Granted Key Formulation Patent for Z160 Business Wire |
| 01:06AM | ZALICUS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 19-Mar-13 08:32AM | AcelRx Pharmaceutical's Potential Billion-Dollar Treatment Under The Radar at Seeking Alpha |
| 08:02AM | InPlay: Zalicus presents data demonstrating advantages of state-dependent ion channel screening says 'it may be possible to broaden the therapeutic window, minimize adverse effects' Briefing.com |
| 08:02AM | Zalicus presents data on state-dependent ion channel screening theflyonthewall.com |
| 08:00AM | Zalicus Presents Data Demonstrating Advantages of State-Dependent Ion Channel Screening Business Wire |
| 01:05AM | ZALICUS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 18-Mar-13 09:28AM | A Study Of 3 Biotechs - A Story Of Hope, Potential And Partnerships at Seeking Alpha |
| 13-Mar-13 01:04PM | ZALICUS INC. Financials EDGAR Online Financials |
| 07-Mar-13 07:27PM | New Star Analyst Rankings for Zalicus Inc. StarMine +7.69% |
| 04:17PM | ZALICUS INC. Files SEC form 10-K, Annual Report EDGAR Online |
| 01:00PM | Why Zalicus' Stock Intrigues at Seeking Alpha |
| 06-Mar-13 07:37AM | ZALICUS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online |
| 07:30AM | Zalicus Reports Financial Results for the Fourth Quarter and Year End 2012 Business Wire |
| 27-Feb-13 08:20AM | U.S. Food and Drug Administration Approved 30% More Drugs in 2012 than the Year Previous Marketwire |
| 21-Feb-13 12:53PM | Speculative Biotech Stocks That Could Bounce 50% On Upcoming Catalysts at Seeking Alpha |
| 20-Feb-13 08:06AM | ZALICUS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 08:00AM | Zalicus Granted Composition-of-Matter Patent for Z944 Business Wire |
| 12-Feb-13 08:01AM | ZALICUS INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online -5.56% |
| 05-Feb-13 08:34AM | Zalicus to Present at the 2013 BIO CEO & Investor Conference Business Wire |
| 31-Jan-13 01:24PM | 5 Stocks Under $10 Set to Soar Higher at TheStreet +5.48% |
| 22-Jan-13 11:15AM | Meeting With Zalicus Management Confirms Z160 Potential; Big Pharma Awaiting Trial Data at Seeking Alpha |
| 18-Jan-13 01:19PM | Zalicus stock drops after CEO sells 113,000 shares at bizjournals.com -5.88% |
| 17-Jan-13 05:28PM | Zalicus CEO Disposes Of 844,090 Shares at Seeking Alpha |
| 15-Jan-13 04:59PM | The Future Of Zalicus In 2013 at Seeking Alpha -7.50% |
| 08:20AM | Biotech Industry Expected to Experience More M&A Activity in 2013 Marketwire |
| 10-Jan-13 01:58PM | Will 2013 Be A Better Year For Zalicus? at Seeking Alpha |
| 09-Jan-13 04:07PM | ZALICUS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 03-Jan-13 02:54PM | 2 Biotech Companies Making Considerable Strides When It Comes To Pain Management at Seeking Alpha +15.15% |
| 07:34AM | ZALICUS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 07:30AM | Zalicus Initiates the Second of Two Phase 2a Studies with Z160 Business Wire |
| 05-Dec-12 04:01PM | Zalicus to Present at the Oppenheimer 23rd Annual Healthcare Conference Business Wire |
| 02:59AM | Top 5 Fiscal Cliff Biotech Buys at Seeking Alpha |
| 04-Dec-12 08:05AM | 3 Small-Cap Biopharmas With Trade Catalysts And Speculation Investment Potential at Seeking Alpha |
| 28-Nov-12 03:38PM | Teva: What Would Be The Best Acquisition Candidate? at Seeking Alpha -8.45% |
| 03:33AM | Smart Day Traders Ring The Register On Acadia And Zalicus at Seeking Alpha |
| 27-Nov-12 08:06AM | ZALICUS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +20.34% |
| 08:00AM | Zalicus Z160 for Chronic Neuropathic Pain Selected as a Top 10 Project to Watch Business Wire |
| 26-Nov-12 01:35PM | Zalicus: Bears And Bulls at Seeking Alpha |
| 20-Nov-12 05:04PM | Pfizer: Does it Need a Future Substitute for Lyrica? at Motley Fool -5.26% |
| 19-Nov-12 08:30AM | Biotech Industry Experiencing More FDA New Drug Approvals in 2012 Marketwire +7.55% |
| 08:20AM | Biotech Industry Experiencing More FDA New Drug Approvals in 2012 Marketwire |
| 16-Nov-12 01:04PM | ZALICUS INC. Financials EDGAR Online Financials +15.22% |
| 10-Nov-12 09:30AM | New Star Analyst Rankings for Zalicus Inc. StarMine |
| 09-Nov-12 09:32AM | New Star Analyst Rankings for Zalicus Inc. StarMine |
| 08-Nov-12 07:36AM | ZALICUS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online -5.66% |
| 07:30AM | Zalicus Reports Financial Results for the Third Quarter 2012 Business Wire |
| 06-Nov-12 12:54PM | Acadia Pharma Selling Stock Ahead of Key Study Results at TheStreet |
| 31-Oct-12 03:22PM | Why Does Sanofi Want To Sublicense Prednisporin? at Seeking Alpha -6.67% |
| 26-Oct-12 08:20AM | Critical Drugs Deemed to Offer Societal Benefit Could See Fast FDA Approval Process Marketwire |
| 25-Oct-12 07:15AM | ZALICUS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +6.90% |
| 07:03AM | InPlay: Zalicus Licensee, Sanofi (SNY), Provides Status Update on Prednisporin (FOV1101); Sanofi to Continue Product Development Under a Third-Party Sublicense Briefing.com |
| 07:00AM | Zalicus Licensee, Sanofi, Provides Status Update on Prednisporin (FOV1101) Business Wire |
| 22-Oct-12 04:06PM | ZALICUS INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran EDGAR Online |
| 15-Oct-12 02:22PM | 3 Small-Cap Healthcare Companies That Have Bottomed Out In October at Seeking Alpha |
| 11-Oct-12 08:25AM | Biotech Industry Looks to Benefit From New Act Designed to Promote R&D Joint Ventures Marketwire |
| 08:25AM | Biotech Industry Looks to Benefit From New Act Designed to Promote R&D Joint Ventures Marketwire |
| 08:20AM | Biotech Industry Looks to Benefit From New Act Designed to Promote R&D Joint Ventures Marketwire |
| 10-Oct-12 04:50PM | Home Depot Downgraded to Perform and 4 Downgraded Shares to Watch at Wall St. Cheat Sheet -6.25% |
| 02:56PM | Home Depot Downgraded to Perform and 4 Downgraded Shares to Watch at Wall St. Cheat Sheet |
| 01:33PM | A Bare Bones Valuation On Zalicus: Over 40% Upside Potential at Seeking Alpha |
| 01:21PM | Home Depot Downgraded to Perform and 4 Downgraded Shares to Watch at Wall St. Cheat Sheet |
| 09-Oct-12 09:11PM | Zalicus downgraded by MLV & Co Briefing.com -7.25% |
| 05-Oct-12 04:12PM | Is Zalicus Really A Bad Investment? at Seeking Alpha |
| 02-Oct-12 10:36AM | Zogenix: Upcoming Catalysts Should Provide Upside at Seeking Alpha |
| 28-Sep-12 08:55AM | Tracking Recent Buy Calls And Investments By The Maxim Group at Seeking Alpha |
| 26-Sep-12 08:20AM | Faster FDA Review Process a Contributing Factor to Biotech Industry's Rise in 2012 Marketwire |
| 17-Sep-12 10:48AM | More Evidence For Catalyst's Potential Vigabatrin Success at Seeking Alpha |
| 14-Sep-12 11:56AM | Prednisporin: A Well-Kept Secret at Seeking Alpha |
| 12-Sep-12 10:00AM | ZLCS - Moving To Neutral on Zalicus Zacks Small Cap Research +11.39% |
| 11-Sep-12 01:31PM | Why Zalicus and Geron Shares Plunged at Motley Fool |
| 11:59AM | Zalicus Has Sufficient Funds Until 2014 at Seeking Alpha |
| 10:17AM | Equity Brief: Upgrades and Downgrades for September 11th: SLGN, SNSS, SYNC, TIBX, TTEK, URBN, WPI Thomson Reuters ONE |
| 10:12AM | Equity Brief: Upgrades and Downgrades for September 10th: OSK, PBCT, PKX, PRSS, PXP, RCL, SHIP, SMA, SNI Thomson Reuters ONE |
| 08:39AM | Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha |
| 01:44AM | Zalicus downgraded by Rodman & Renshaw Briefing.com |
| 10-Sep-12 03:35PM | Zalicus To Discontinue Development Of Synavive - What Now? at Seeking Alpha -43.17% |
| 02:46PM | "Better Than Nothing" Doesn't Cut It for Zalicus at Motley Fool |
| 02:30PM | Zalicus slumps after ending Synavive development AP |
| 11:56AM | Zalicus Misses Key Secondary Endpoint at Seeking Alpha |
| 08:08AM | Zalicus downgraded by MLV & Co Briefing.com |
